Can what's on your plate today shape your health tomorrow? 🍽️ According to research found in the National Library of Medicine (NLM)'s publication Gastrointestinal Cancers, edited by Jose Andres Morgado-Diaz, PhD, red and processed meats significantly increase the risk of colon cancer, while diets rich in fruits, vegetables, and fibre provide protective benefits. Using liquid biopsy technology, SAGITTARIUS aims to match the right treatment to the right patient at the right time, improving therapy effectiveness and reducing unnecessary side effects. This approach not only increases survival chances but also enhances quality of life. On this #WorldFoodDay, let’s remember that the choices we make about what we eat can be as influential as cutting-edge technology in preventing and managing cancer. By combining healthier lifestyles with innovations like the SAGITTARIUS project, we can empower patients and ensure better outcomes for those at risk of colon cancer. Source: https://lnkd.in/ey6mUaV6 #SAGITTARIUSProject #gastriccancerprevention #obesityawareness #healthychoices #cancerprevention #gastriccancer Health Europa European Health and Digital Executive Agency (HaDEA) European Commission FAO
Sagittarius EU Project
Public Health
Within the SAGITTARIUS project, researchers aim to optimise the clinical management of locoregional colon cancer.
About us
The overarching objective of SAGITTARIUS is to use liquid biopsy (LB), a new innovative assay for detecting the circulating tumour DNA (ctDNA) in the blood, to personalise the post-surgical care of patients with loco-regional stage III and high-risk stage II colon cancer (LRCC).
- Website
-
http://www.sagittarius-horizon.eu/
External link for Sagittarius EU Project
- Industry
- Public Health
- Company size
- 11-50 employees
- Type
- Nonprofit
Updates
-
Why talk about the link between weight and cancer? 🤔 Obesity has been identified as a contributor to several cancer types, including colon cancer. Research shows that individuals with obesity are at a higher risk of developing colon cancer. Maintaining a healthy weight can significantly lower the risk of cancer and improve treatment outcomes for those already diagnosed. The Sagittarius project focuses on improving post-surgical care for colon cancer patients by using personalized approaches guided by advanced diagnostics. By ensuring patients receive tailored care, the project not only aims to enhance recovery but also to promote healthier lifestyles that can reduce the long-term burden of colon cancer. #WorldObesityDay #SAGITTARIUSProject #gastriccancerprevention #obesityawareness #healthychoices #cancerprevention #gastriccancer World Obesity Federation
-
Are you ok? 🫂 Mental health challenges often extend far beyond the diagnosis and treatment of colon cancer. Many patients could struggle with anxiety, fear of recurrence, and emotional exhaustion before, during, and/or after treatment. The psychological impact could also affect their carer and their families, who navigate the emotional toll alongside them. Post-surgical care is a critical time when mental health can be fragile as patients transition from survival mode to a new normal. By ensuring patients receive the right treatment at the right time, avoid unnecessary side effects, and experience better outcomes, the SAGITTARIUS project aims to contribute to a better quality of life and alleviate the burden. #WorldMentalHealthDay #SagittariusEU #SagittariusProject #CRC #ColonCancerCare World Health Organization World Federation for Mental Health IFOM AIRC - Foundation for Cancer Research NGO Università Bocconi Hospital del Mar Research Institute Digestive Cancers Europe SporeData Inc. Vall d'Hebron Institute of Oncology (VHIO) Charité - Universitätsmedizin Berlin European Commission European Health and Digital Executive Agency (HaDEA) European Parliament European Union
-
💡Many colorectal cancer patients will face the life-changing reality of living with a temporary or permanent colostomy. On World Ostomy Day, we recognize their resilience and the importance of personalized care in improving outcomes. At Sagittarius, we are committed to advancing innovative approaches for the post-surgical treatment of colon cancer. By focusing on more precise, tailored treatment pathways, we aim to reduce unnecessary interventions and improve the quality of life for patients—including those with an ostomy. World Ostomy Day, celebrated every three years, raises awareness, breaks stigma, and advocates for better care and support for those living with an ostomy. #WorldOstomyDay #cancercare #cancer #SAGITTARIUSProject #LiquidBiopsy #ColorectalCancer
-
Today on World Metastatic Colorectal Cancer Day, we recognise the impact of metastatic CRC, where cancer has spread beyond the colon. Most commonly the liver or lungs. While SAGITTARIUS is dedicated to high-risk stage II and stage III CRC, we stand in solidarity with all CRC patients and their loved ones. 🔬 Discover more about our trial and how we're working to make a difference: (Link in bio). #WorldMetastaticCRCDay #CRC #CancerResearch #SAGITTARIUSProject #ClinicalTrials
-
🔬On World Cancer Research Day, SAGITTARIUS calls for a unified global effort to prevent, diagnose, and treat cancer. Our trial explores liquid biopsy to tailor treatments for colon cancer patients, aiming to enhance outcomes and reduce unnecessary interventions. Collectively, we can revolutionize cancer care and improve patient outcomes. ✨ #worldcancerresearchday #gastriccancer #cancercare #cancerresearch #cancer Università Bocconi Hospital del Mar Digestive Cancers Europe SporeData Inc. Vall d'Hebron Institute of Oncology (VHIO) Charité - Universitätsmedizin Berlin IFOM European Commission European Parliament EU Science, Research and Innovation Cogentech Società Benefit srl European Health and Digital Executive Agency (HaDEA) AIRC - The Italian Foundation for Cancer Research ETS
-
✨On World Patient Safety Day, we’re proud to spotlight the SAGITTARIUS project! Our clinical trial is exploring a new approach to treating high-risk stage II and III colon cancer post-surgery. By using liquid biopsy to personalise treatment, we aim to improve patient outcomes and minimise unnecessary treatments. This could be a game-changer in post-surgical care!🔬 #WorldPatientSafetyDay #SAGITTARIUSProject #LiquidBiopsy #ColorectalCancer Università Bocconi Hospital del Mar Digestive Cancers Europe SporeData Inc. Vall d'Hebron Institute of Oncology (VHIO) Charité - Universitätsmedizin Berlin IFOM European Commission European Parliament EU Science, Research and Innovation Cogentech Società Benefit srl European Health and Digital Executive Agency (HaDEA) AIRC - The Italian Foundation for Cancer Research ETS
-
🎤 Many SAGITTARIUS partners experts will contribute to the advancement of cancer research by attending the ESMO 2024, which is taking place now (September 13th-17th) in Barcelona! Here are some interesting sessions that will be held or moderated by some SAGITTARIUS Principal Investigators: 📅 Saturday, 14 Sept 2024, 18:35-18:45: Sebastian Stintzing (Charité - Universitatsmedizin Berlin, Hematology, Oncology, and Cancer Immunology Dept., Berlin) will present the session "Navigating complexities in patient cases: what's your next treatment for refractory disease?" 📅 Sunday, 15 Sep 2024, 15:15-15:25: Clara Montagut Viladot (Hospital del Mar - Parc de Salut Mar, Dept. Medical Oncology, Barcelona) will be an invited discussant in a session about lower digestive gastrointestinal tumors; 📅 Monday, 16 Sep 2024, 14:45-16:15: Maria Elena Élez Fernandez (Vall d'Hebron University Hospital, Medical Oncology Dept., Barcelona) will moderate the special symposium "New technology, new ideas: What is on the horizon for colorectal cancer?" 📜 Also, on Saturday 14 Sept 2024, 15:25-15:35, there will be the oral presentation of the first translational results of PEGASUS, the IFOM-AIRC trial that laid the foundations of SAGITTARIUS: "Transcriptional features of stage IIT4N0/III colon cancer associated with residual disease and ctDNA status after surgery in the PEGASUS trial" (presented by Enzo Medico, IRCCS Istituto di Candiolo, Italy, and co-authored by Silvia Marsoni, IFOM-IEO Campus, and Sara Lonardi, Istituto Oncologico Veneto IRCCS, among the others). To find out more about SAGITTARIUS, stay tuned and visit the website: https://lnkd.in/ehy55__6 #ESMO24 #SagittariusEU #SagittariusProject #CRC #ColonCancerCare #HorizonEU #EUCancerMission IFOM Fondazione AIRC per la Ricerca sul Cancro ETS Università Bocconi Hospital del Mar Research Institute Digestive Cancers Europe SporeData Inc. Vall d'Hebron Institute of Oncology (VHIO) Charité - Universitätsmedizin Berlin European Commission European Health and Digital Executive Agency (HaDEA)
-
✨Today we are taking an important step in the fight against cancer, together with other research projects! 👉 The SAGITTARIUS experts are joining the Cluster “Diagnosis and Treatment” Annual Meeting, that brings together experts and projects focused on cancer funded by Horizon Europe to work together more effectively. By sharing knowledge and working closely with one another, this Cluster is helping to speed up progress in cancer diagnosis and treatment. It is all about making sure the latest research benefits everyone across Europe. 👐Thank you to all who contributed to this meaningful collaboration! Sagittarius EU Project CARE 1 De-Escalate Impact-AML IMPORTANT EU Project InterALL-2020 LEGATO Project Liveration PragmaTIL PRIME-ROSE SALVOVAR STREXIT 2 Project #EUCancerMission #SagittariusEU IFOM Fondazione AIRC per la Ricerca sul Cancro ETS Hospital del Mar Università Bocconi Digestive Cancers Europe SporeData Inc. Vall d'Hebron Institute of Oncology (VHIO) Charité - Universitätsmedizin Berlin European Health and Digital Executive Agency (HaDEA)
-
🎙️Meet Dr. Clara Montagut of the Gastrointestinal Cancer Unit, in the Medical Oncology Department at Hospital del Mar in Barcelona. Hospital del Mar is a leader in healthcare knowledge, education, and research. As a premier public health services institution, it drives progress in biomedicine and shapes future health professionals, committed to clinical excellence, innovation, and social responsibility. Offering comprehensive healthcare services, including acute care, public health, mental health, and primary care, the institute is internationally recognized for its biomedical research. It collaborates with researchers and clinicians globally. With flexible management and strategic alliances, Hospital del Mar plays a key role in advancing entrepreneurial policies in healthcare. Within the SAGITTARIUS Project, Hospital del Mar is a Consortium Member and a Clinical Trial Coordinator in Spain. 🤔Would you like to know more? The next video will be coming soon! Please SHARE, LIKE, and VISIT our website https://lnkd.in/d_ES8Xnz ! #SAGITTARIUSEU #SAGITTARIUSProject #CRC #ColonCancerCare #HorizonEU #eucancermission Università Bocconi Hospital del Mar Digestive Cancers Europe SporeData Inc. Vall d'Hebron Institute of Oncology (VHIO) Charité - Universitätsmedizin Berlin IFOM European Commission European Parliament EU Science, Research and Innovation Cogentech Società Benefit srl European Health and Digital Executive Agency (HaDEA)